CoreWeave, an AI computing solutions provider, adjusted its IPO pricing amid market volatility, raising $1.5 billion at a $19 billion valuation by pricing shares at $40, below the expected $47-$55 range, to align with buyer interest amidst macroeconomic challenges.
Nvidia's substantial $250 million order for CoreWeave's AI chip-powered computing services is expected to bolster the latter's $40 per share IPO bid, signaling a potential revival for the sluggish IPO market.
The iconic Napster music sharing service from the 90s has been revived, acquired for $207 million by Infinite Reality to create immersive virtual worlds where music fans can attend concerts and listening parties together, aiming to revolutionize the streaming experience with community-driven 3D spaces.
Nine EU nations are accelerating efforts to bolster Europe's semiconductor industry, aiming to unveil proposals by summer for a new funding program that addresses gaps in chip packaging and production, while boosting demand to attract company investments.
Browser Use, a tool that converts website elements into an AI-friendly format, has secured $17 million in seed funding to become a crucial layer enabling AI agents to interact with websites seamlessly, backed by Felicis Ventures, Paul Graham, A Capital, and Nexus Venture Partners.
In a surprising move, Microsoft declined a nearly $12 billion deal for data center capacity, allowing OpenAI to swiftly secure the contract, highlighting the intense competition and high stakes in the AI industry as CoreWeave's impending IPO is viewed as a bellwether for the sector.
PwC has signed a groundbreaking deal to become the first enterprise reseller of OpenAI's ChatGPT, integrating the AI technology into its workforce and services, and positioning itself as a leader in AI adoption and scaling for clients.
Perplexity, an AI search startup, proposes an ambitious $30-50 billion bid to acquire TikTok's U.S. operations, rebuild its algorithm transparently and integrate its search capabilities, seeking funding at an $18 billion valuation.
Y Combinator startups are experiencing unprecedented growth, with AI driving rapid product development and profitability, allowing small teams to reach $10 million in revenue, signaling a shift from growth-at-all-costs to sustainable business models.
Insilico Medicine, an AI-driven drug discovery company, raised $110 million in Series E funding to propel its AI platform Pharma.AI, advance its drug pipeline, and bolster biopharmaceutical R&D, harnessing biology, clinical data, and generative chemistry for innovative drug development.